Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Barret

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
International Urology and Nephrology|October 6, 2025
Erectile dysfunction following prostate biopsy: a comparative analysis of transrectal versus transperineal approachesO Ermis, M G Sonmez, A Tozsin, et al.
Actas Urologicas Espanolas|November 29, 2016
Higher number of transrectal ultrasound guided prostate biopsy cores is associated with higher blood loss and perioperative complications in robot assisted radical prostatectomyA Carneiro, A Sivaraman, R Sanchez-Salas, et al.
Actas Urologicas Espanolas|December 24, 2019
Magnetic resonance as imaging diagnostic tool in prostate cancer: New evidences-The EAU Section of Uro-Technology positionM Álvarez-Maestro, J Gómez Rivas, J Quesada Olarte, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 7, 2022
[DNA repair gene alterations testing in prostate cancer : A practical update by the prostate cancer committee of the french association of urology]G Ploussard, J-B Beauval, R Mathieu, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 18, 2022
French AFU Cancer Committee Guidelines - Update 2022-2024: prostate cancer - Management of metastatic disease and castration resistanceG Ploussard, G Roubaud, E Barret, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|January 31, 2023
Narrative review of PET/CT performances at biochemical recurrence in prostate cancer after radical prostatectomy and impact on patient disease management: Revue narrative à propos des performances de la TEP/TDM en cas de récidive biochimique après prostatectomie radicale dans le cancer de la prostate et impact sur la prise en charge des patientsM Lasserre, P Sargos, E Barret, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 1, 2022
[Recent advances in the management of localized high-risk prostate cancer: An update by the Prostate Cancer Committee of the French Association of Urology]M Baboudjian, J-B Beauval, E Barret, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 18, 2022
French AFU Cancer Committee Guidelines - Update 2022-2024: prostate cancer - Diagnosis and management of localised diseaseG Ploussard, G Fiard, E Barret, et al.
Actas Urologicas Espanolas|August 21, 2016
High intensity focused ultrasound with Focal-One<sup>®</sup> device: Prostate-specific antigen impact and morbidity evaluation during the initial experienceJ I Perez-Reggeti, R Sanchez-Salas, A Sivaraman, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|January 31, 2023
How PET-CT is Changing the Management of Non-metastatic Castration-resistant Prostate Cancer?: Comment la TEP-TDM Peut Modifier la Prise en Charge du Cancer de la Prostate Non Métastatique Résistant à la Castration ?M Baboudjian, M Gauthé, E Barret, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
International Urology and Nephrology|October 6, 2025
Erectile dysfunction following prostate biopsy: a comparative analysis of transrectal versus transperineal approachesO Ermis, M G Sonmez, A Tozsin, et al.
Actas Urologicas Espanolas|November 29, 2016
Higher number of transrectal ultrasound guided prostate biopsy cores is associated with higher blood loss and perioperative complications in robot assisted radical prostatectomyA Carneiro, A Sivaraman, R Sanchez-Salas, et al.
Actas Urologicas Espanolas|December 24, 2019
Magnetic resonance as imaging diagnostic tool in prostate cancer: New evidences-The EAU Section of Uro-Technology positionM Álvarez-Maestro, J Gómez Rivas, J Quesada Olarte, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 7, 2022
[DNA repair gene alterations testing in prostate cancer : A practical update by the prostate cancer committee of the french association of urology]G Ploussard, J-B Beauval, R Mathieu, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 18, 2022
French AFU Cancer Committee Guidelines - Update 2022-2024: prostate cancer - Management of metastatic disease and castration resistanceG Ploussard, G Roubaud, E Barret, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|January 31, 2023
Narrative review of PET/CT performances at biochemical recurrence in prostate cancer after radical prostatectomy and impact on patient disease management: Revue narrative à propos des performances de la TEP/TDM en cas de récidive biochimique après prostatectomie radicale dans le cancer de la prostate et impact sur la prise en charge des patientsM Lasserre, P Sargos, E Barret, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 1, 2022
[Recent advances in the management of localized high-risk prostate cancer: An update by the Prostate Cancer Committee of the French Association of Urology]M Baboudjian, J-B Beauval, E Barret, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 18, 2022
French AFU Cancer Committee Guidelines - Update 2022-2024: prostate cancer - Diagnosis and management of localised diseaseG Ploussard, G Fiard, E Barret, et al.
Actas Urologicas Espanolas|August 21, 2016
High intensity focused ultrasound with Focal-One<sup>®</sup> device: Prostate-specific antigen impact and morbidity evaluation during the initial experienceJ I Perez-Reggeti, R Sanchez-Salas, A Sivaraman, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|January 31, 2023
How PET-CT is Changing the Management of Non-metastatic Castration-resistant Prostate Cancer?: Comment la TEP-TDM Peut Modifier la Prise en Charge du Cancer de la Prostate Non Métastatique Résistant à la Castration ?M Baboudjian, M Gauthé, E Barret, et al.
Pageof 6